Johan Neyts


Meet Johan Neyts

Johan Neyts is full professor of Virology at the KU Leuven, Belgium and Head of the Laboratory of Virology, Antiviral Drug & Vaccine Research at the Rega Institute for Medical Research, Department of Microbiology, Immunology & Transplantation, KU Leuven, Belgium.

Neyts lab has a long-standing expertise in the development of antivirals strategies and drugs against emerging and neglected viral infections such as dengue and other flaviviruses, Chikungunya and other alphaviruses, enteroviruses, noroviruses, HEV and rabies and is intensively involved in the search for antiviral strategies against SARS-CoV2.  A second focus of the laboratory, together with the team of Prof. Kai Dallmeier is the development of the PLLAV (Plasmid Launched Live Attenuated Virus) vaccine technology, which is based on the yellow fever virus vaccine as a vector and allows to rapidly engineer highly thermostable vaccines against multiple viral pathogens. Johan is past-president of the International Society for Antiviral Research. He is the co-founder of KU Leuven spin-offs AstriVax and Okapi Sciences. He published >620 papers in peer reviewed journals, has given ~300 invited lectures and provides content to a larger audience via lay-press. 

Meet the Management Team & Founders

Managing Director

Dirk Roymans

Dirk has more than 20 years of experience in pharmaceutical discovery research and clinical drug development in mid-sized ...
Head of Operations

Aleksandra Siekierska

Aleksandra has about 15 years of academic experience in the field of molecular and cell biology and neuroscience. She obta...

Patrick Chaltin

Patrick Chaltin is the Managing Director of the Centre for Drug Design and Discovery (CD3) since its start-up in 2006.